[FURL=https://www.industryarc.com/Report/17362/heparin-market.html]Heparin Market[/FURL] size is valued at $10.86Bn by 2019, and is anticipated to grow at a CAGR of 7.19% during the forecast period 2020-2025. The Heparin Market growth rate is attributed to the increasing incidences of coagulation disorders, substantial growth in the number of the people suffering from diseases like venous thromboembolism and heart diseases. is used to prevent formation of blood clots caused by certain medical conditions or medical procedures. It is used in the treatment for various health conditions such as acute coronary syndrome, deep-vein thrombosis, pulmonary embolism, atrial fibrillation, and is also used during heart surgery for carrying out cardiopulmonary bypass as well as hemofiltration. From increasing incidence of venous thromboembolism and cardiovascular disorders Increasing incidence of venous thromboembolism and cardiovascular disorders to increase in government funding toward improving healthcare facilities and extensive research and development (R&D) activities to develop heparin with improved therapeutic potential and minimal side-effects is anticipated to propel the Heparin Market during the forecast period 2020-2025. Key Takeaways
North America dominated the Heparin Market with a share of 39% in the year 2019.
The factors such as increase in mortality and prevalence of chronic diseases like cardiovascular disorders as heparin acts as an anticoagulant that prevents the formation of blood clots, it is used before surgery to reduce the risk of in the veins, arteries, or lungs are amongst the major factor projected to impel growth of Heparin Market.
Improving healthcare infrastructure, higher healthcare expenditure levels, high patient awareness are the key factors owing to the growth in the segment during forecast period 2020-2025.
equest for Sample of the Report @ [FURL]https://www.industryarc.com/pdfdownload.php?id=17362[/FURL]
Application Type- Segment Analysis
On the basis of Application type, deep vein thrombosis segment held the major share of the market in terms of revenue and is poised to grow with a CAGR of 7.1%. The reason is set to be attributed to the increasing awareness of thrombosis such as pulmonary embolism (PE) and deep vein thrombosis (DVT). Increasing prevalence and incidence of heart-related disorders is anticipated to further expand the consumption rate over the projection period of 2020-2025.
Drivers – Heparin Market
Increasing Introduction of Biosimilar LMWH Anticoagulants Globally
UHT Processing Industry Outlook: Heparin Market top 10 companies are LEO Pharma A/S, Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd., Novartis AG, Sanofi, Pfizer Inc, F. Hoffmann-La Roche Ltd, Mylan N.V., Aspen Holdings, changzhaou Qianhong Bio-pharma Co., ltd., Eisai Co., Ltd., Hebei Changshan Biochemical Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, and others.
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.